Rogier W Rooswinkel1, Daan S W Berbers2, Eric H J H M Claassen3, Sander van Deventer1. Show Affiliations » 1. Forbion Capital Partners, Naarden, the Netherlands. 2. Biogeneration Ventures, Naarden, the Netherlands. 3. Vrije Universiteit, Amsterdam, the Netherlands.
Abstract
Year: 2016 PMID： 27824845 DOI： 10.1038/nbt.3712
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908